Spoken Alpha
EDSA
Edesa Biotech, Inc.
Overview
Edesa Biotech, Inc is a Healthcare company operating in Biotechnology with a $30.8M market cap.
EDSA missed consensus EPS by 0.4% in Q3 FY2026, reported Aug 12, 2026.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-10-04.
Transcripts
Recent earnings calls
No earnings calls indexed for EDSA yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add EDSA, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q3 FY20262026-08-12EPS$-0.60 vs $-0.44-36.4%Rev$0 vs ——EODHD
- Q2 FY20262026-05-13EPS$-0.49 vs $-0.26-88.5%Rev$50.9K vs ——EODHD
- Q1 FY20262026-02-12EPS$-0.28 vs $-0.45+37.8%Rev$0 vs ——EODHD
- Q4 FY20252025-12-11EPS$-0.32 vs $-0.56+42.9%Rev$0 vs ——EODHD
- Q3 FY20252025-08-07EPS$-0.25 vs $-0.26+3.9%Rev$0 vs ——EODHD
- Q2 FY20252025-05-13EPS$-0.30 vs $-0.29-3.5%Rev$0 vs ——EODHD
- Q1 FY20252025-02-13EPS$-0.48 vs $-0.31-54.8%Rev$0 vs ——EODHD
- Q4 FY20242024-12-12EPS$-0.29 vs $-0.54+46.3%Rev$0 vs ——EODHD
- Q3 FY20242024-08-08EPS$-0.52 vs $-0.58+10.3%Rev$0 vs ——EODHD
- Q2 FY20242024-05-09EPS$-0.58 vs $-0.69+15.9%Rev$0 vs ——EODHD
- Q1 FY20242024-02-08EPS$-0.54 vs $-1.21+55.4%Rev$0 vs ——EODHD
- Q4 FY20232023-12-14EPS$-0.60 vs $-0.71+15.5%Rev$-1.1M vs ——EODHD
- Q3 FY20232023-08-08EPS$-0.70 vs $-1.21+42.1%Rev$0 vs ——EODHD
- Q2 FY20232023-05-10EPS$-0.84 vs $-1.21+30.6%Rev$0 vs ——EODHD
- Q1 FY20232023-02-09EPS$-0.91 vs $-1.33+31.6%Rev$1.1M vs ——EODHD
- Q4 FY20222022-12-15EPS$-0.02 vs $-0.39+94.9%Rev$0 vs ——EODHD
- Q3 FY20222022-08-11EPS$-2.59 vs $-3.01+14.0%Rev$0 vs ——EODHD
- Q2 FY20222022-05-12EPS$-2.31 vs $-2.57+10.1%Rev$0 vs ——EODHD
- Q1 FY20222022-02-13EPS$-0.33 vs $-0.40+17.5%Rev$0 vs ——EODHD
- Q4 FY20212021-12-27EPS$-2.86 vs $-2.94+2.7%Rev$-3.5M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-08-12 | $-0.60 | $-0.44 | -36.4% | $0 | — | — | EODHD |
| Q2 FY2026 | 2026-05-13 | $-0.49 | $-0.26 | -88.5% | $50.9K | — | — | EODHD |
| Q1 FY2026 | 2026-02-12 | $-0.28 | $-0.45 | +37.8% | $0 | — | — | EODHD |
| Q4 FY2025 | 2025-12-11 | $-0.32 | $-0.56 | +42.9% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-08-07 | $-0.25 | $-0.26 | +3.9% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-05-13 | $-0.30 | $-0.29 | -3.5% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-02-13 | $-0.48 | $-0.31 | -54.8% | $0 | — | — | EODHD |
| Q4 FY2024 | 2024-12-12 | $-0.29 | $-0.54 | +46.3% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-08-08 | $-0.52 | $-0.58 | +10.3% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-05-09 | $-0.58 | $-0.69 | +15.9% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-02-08 | $-0.54 | $-1.21 | +55.4% | $0 | — | — | EODHD |
| Q4 FY2023 | 2023-12-14 | $-0.60 | $-0.71 | +15.5% | $-1.1M | — | — | EODHD |
| Q3 FY2023 | 2023-08-08 | $-0.70 | $-1.21 | +42.1% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-05-10 | $-0.84 | $-1.21 | +30.6% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-02-09 | $-0.91 | $-1.33 | +31.6% | $1.1M | — | — | EODHD |
| Q4 FY2022 | 2022-12-15 | $-0.02 | $-0.39 | +94.9% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-08-11 | $-2.59 | $-3.01 | +14.0% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-05-12 | $-2.31 | $-2.57 | +10.1% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-02-13 | $-0.33 | $-0.40 | +17.5% | $0 | — | — | EODHD |
| Q4 FY2021 | 2021-12-27 | $-2.86 | $-2.94 | +2.7% | $-3.5M | — | — | EODHD |
Source: EODHD. EDSA reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Pardeep NijhawanCEO7 yr 5 mono recorded callsCurrent
- Peter J WeilerCFO1 yr 6 mono recorded callsCurrent
- Michael J BrooksPresident7 yr 5 mono recorded callsCurrent
- Nijhawan Medicine Professional Corp PardeepCEO2 yr 6 mono recorded callsFormer
- Frank R OakesCEO2 yr 2 mono recorded callsFormer
- Stephen LemieuxCFO1 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for EDSA.
$ curl https://api.spokenalpha.com/v1/companies/EDSAFAQ
Frequently asked about EDSA
Where can I find Edesa Biotech, Inc.'s (EDSA) earnings call transcripts?
Spoken Alpha indexes EDSA's earnings call transcripts at https://spokenalpha.com/companies/EDSA. Each call links to attributed speakers and parsed analyst Q&A. Edesa Biotech, Inc.'s own investor relations page is at https://www.edesabiotech.com/investors/.
What sector is EDSA in?
Edesa Biotech, Inc. (EDSA) operates in the Healthcare sector (Biotechnology industry).